Nuveen LLC Invests $341,000 in Cronos Group Inc. $CRON

Key Points

• Nuveen LLC acquired a new stake in Cronos Group Inc. by purchasing 189,422 shares, valued at approximately $341,000.
• Recent trading data shows Cronos Group's stock price is currently at $2.50, with a 52-week low of $1.60 and a high of $2.77.
• Cronos Group reported a loss of ($0.10) EPS for the most recent quarter, missing analyst expectations, while revenue was reported at $33.46 million.

Nuveen LLC acquired a new stake in Cronos Group Inc. (NASDAQ:CRON - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 189,422 shares of the company's stock, valued at approximately $341,000.

Several other institutional investors also recently modified their holdings of CRON. Formidable Asset Management LLC boosted its stake in Cronos Group by 2.1% during the 4th quarter. Formidable Asset Management LLC now owns 278,398 shares of the company's stock worth $562,000 after acquiring an additional 5,637 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of Cronos Group by 140.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after purchasing an additional 8,019 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in Cronos Group by 53.7% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 47,800 shares of the company's stock worth $86,000 after buying an additional 16,700 shares during the last quarter. Aigen Investment Management LP acquired a new position in shares of Cronos Group during the 1st quarter worth approximately $35,000. Finally, Two Sigma Advisers LP raised its position in shares of Cronos Group by 8.0% in the fourth quarter. Two Sigma Advisers LP now owns 275,357 shares of the company's stock valued at $556,000 after purchasing an additional 20,400 shares during the period. Institutional investors and hedge funds own 8.71% of the company's stock.

Cronos Group Trading Up 2.0%

NASDAQ CRON traded up $0.05 on Thursday, hitting $2.58. 1,657,479 shares of the company were exchanged, compared to its average volume of 3,019,516. Cronos Group Inc. has a 12 month low of $1.60 and a 12 month high of $2.77. The company has a market cap of $987.86 million, a PE ratio of 51.60 and a beta of 1.13. The stock has a fifty day moving average of $2.30 and a 200-day moving average of $2.03.

Cronos Group (NASDAQ:CRON - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.08). The business had revenue of $33.46 million for the quarter, compared to the consensus estimate of $45.73 million. Cronos Group had a negative return on equity of 3.78% and a net margin of 14.19%. On average, analysts expect that Cronos Group Inc. will post -0.03 earnings per share for the current year.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Cronos Group from a "sell" rating to a "hold" rating in a research note on Saturday, August 30th.

Cronos Group Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.